Pages that link to "Q35012413"
The following pages link to Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis. (Q35012413):
Displaying 50 items.
- Progress towards gene therapy for cystic fibrosis (Q22306014) (← links)
- Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease (Q24198270) (← links)
- Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease (Q24202357) (← links)
- Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease (Q24245035) (← links)
- Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease (Q24245040) (← links)
- Digitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-8 from cystic fibrosis lung epithelial cells (Q24562089) (← links)
- Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease (Q26471459) (← links)
- Cell Penetrating Peptide Conjugated Chitosan for Enhanced Delivery of Nucleic Acid (Q26774462) (← links)
- Human amnion epithelial cells induced to express functional cystic fibrosis transmembrane conductance regulator (Q27316048) (← links)
- Poly(ester amine)-mediated, aerosol-delivered Akt1 small interfering RNA suppresses lung tumorigenesis (Q28384723) (← links)
- CRISPR-Cas9 directed knock-out of a constitutively expressed gene using lance array nanoinjection (Q28830781) (← links)
- Characterization of polyion complex micelles designed to address the challenges of oligonucleotide delivery (Q33331415) (← links)
- In vitro and in vivo functional characterization of gutless recombinant SV40-derived CFTR vectors (Q33647647) (← links)
- Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis (Q33715133) (← links)
- Repeated aerosol delivery of carboxyl-terminal modulator protein suppresses tumor in the lungs of K-rasLA1 mice (Q33744433) (← links)
- Common gene therapy viral vectors do not efficiently penetrate sputum from cystic fibrosis patients (Q33921035) (← links)
- Lysophosphatidylcholine as an adjuvant for lentiviral vector mediated gene transfer to airway epithelium: effect of acyl chain length (Q34000604) (← links)
- Nanotechnology approaches for inhalation treatment of fibrosis (Q34449624) (← links)
- Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo. (Q34496721) (← links)
- In vivo evaluation of adeno-associated virus gene transfer in airways of mice with acute or chronic respiratory infection (Q34532759) (← links)
- Immunological hurdles to lung gene therapy. (Q35091006) (← links)
- Gene therapy: theoretical and bioethical concepts (Q35212648) (← links)
- Development of herpesvirus-based episomally maintained gene delivery vectors (Q35753517) (← links)
- Gene therapy for cystic fibrosis: an example for lung gene therapy (Q35904424) (← links)
- Novel molecular approaches to cystic fibrosis gene therapy (Q36012920) (← links)
- Airway gene therapy and cystic fibrosis (Q36079832) (← links)
- In utero gene therapy: current challenges and perspectives. (Q36105888) (← links)
- Role of ATP binding and hydrolysis in the gating of the cystic fibrosis transmembrane conductance regulator (Q36181487) (← links)
- Design and development of polymers for gene delivery (Q36211579) (← links)
- Gene therapy for disorders affecting children, progress and potential (Q36816069) (← links)
- Imaging gene delivery with fluorescence microscopy (Q37038838) (← links)
- Dual-degradable disulfide-containing PEI-Pluronic/DNA polyplexes: transfection efficiency and balancing protection and DNA release (Q37221056) (← links)
- Extracellular barriers in respiratory gene therapy. (Q37369283) (← links)
- Targeted gene delivery to the lung (Q37486747) (← links)
- Balancing protection and release of DNA: tools to address a bottleneck of non-viral gene delivery. (Q37592852) (← links)
- Optimizing aerosol gene delivery and expression in the ovine lung (Q38464450) (← links)
- New and Emerging Treatments for Cystic Fibrosis (Q38532426) (← links)
- The Mucus Barrier to Inhaled Gene Therapy (Q38959100) (← links)
- Self-assembled BolA-like amphiphilic peptides as viral-mimetic gene vectors for cancer cell targeted gene delivery (Q39217800) (← links)
- Late generation lentiviral vectors: evaluation of inflammatory potential in human airway epithelial cells. (Q39850427) (← links)
- Lentivirus-mediated carboxyl-terminal modulator protein gene transfection via aerosol in lungs of K-ras null mice. (Q40160692) (← links)
- Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo (Q40273201) (← links)
- Aerosol delivery of Akt controls protein translation in the lungs of dual luciferase reporter mice (Q40277856) (← links)
- Magnetofection Enhances Lentiviral-Mediated Transduction of Airway Epithelial Cells through Extracellular and Cellular Barriers. (Q40436215) (← links)
- Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung (Q40546852) (← links)
- Disruption of the mucus barrier by topically applied exogenous particles (Q40732392) (← links)
- Efficient delivery of RNA interference oligonucleotides to polarized airway epithelia in vitro (Q41396117) (← links)
- Polyethylenimine-mediated gene delivery to the lung and therapeutic applications. (Q41985187) (← links)
- Sulfhydryl based cationic surfactants and the impact of polyanions on disulfide bond formation: implications for gene transfer vectors (Q45151525) (← links)
- Sendai virus-mediated CFTR gene transfer to the airway epithelium. (Q45402489) (← links)